The American pharmaceutical giant Amgen $AMGN is once again demonstrating its commitment to global growth by investing approximately 200 million dollars in a new technology hub in southern India. This move reinforces the company’s ambition to strengthen its presence in the so-called "pharmacy of the world" and leverage innovative technologies for drug development. During the event on Monday, CEO Robert Bradway emphasized that additional significant investments are planned in the coming years.